IBDEI07R ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3481,0)
 ;;=605.^^33^279^41
 ;;^UTILITY(U,$J,358.3,3481,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3481,1,4,0)
 ;;=4^605.
 ;;^UTILITY(U,$J,358.3,3481,1,5,0)
 ;;=5^Phimosis
 ;;^UTILITY(U,$J,358.3,3481,2)
 ;;=^104159
 ;;^UTILITY(U,$J,358.3,3482,0)
 ;;=601.0^^33^279^43
 ;;^UTILITY(U,$J,358.3,3482,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3482,1,4,0)
 ;;=4^601.0
 ;;^UTILITY(U,$J,358.3,3482,1,5,0)
 ;;=5^Prostatitis, Acute
 ;;^UTILITY(U,$J,358.3,3482,2)
 ;;=^259106
 ;;^UTILITY(U,$J,358.3,3483,0)
 ;;=590.10^^33^279^45
 ;;^UTILITY(U,$J,358.3,3483,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3483,1,4,0)
 ;;=4^590.10
 ;;^UTILITY(U,$J,358.3,3483,1,5,0)
 ;;=5^Pyelonephritis, Acute
 ;;^UTILITY(U,$J,358.3,3483,2)
 ;;=^270369
 ;;^UTILITY(U,$J,358.3,3484,0)
 ;;=590.00^^33^279^46
 ;;^UTILITY(U,$J,358.3,3484,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3484,1,4,0)
 ;;=4^590.00
 ;;^UTILITY(U,$J,358.3,3484,1,5,0)
 ;;=5^Pyelonephritis, Chronic
 ;;^UTILITY(U,$J,358.3,3484,2)
 ;;=^270367
 ;;^UTILITY(U,$J,358.3,3485,0)
 ;;=788.7^^33^279^53
 ;;^UTILITY(U,$J,358.3,3485,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3485,1,4,0)
 ;;=4^788.7
 ;;^UTILITY(U,$J,358.3,3485,1,5,0)
 ;;=5^Urethral Discharge
 ;;^UTILITY(U,$J,358.3,3485,2)
 ;;=^265872
 ;;^UTILITY(U,$J,358.3,3486,0)
 ;;=131.02^^33^279^56
 ;;^UTILITY(U,$J,358.3,3486,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3486,1,4,0)
 ;;=4^131.02
 ;;^UTILITY(U,$J,358.3,3486,1,5,0)
 ;;=5^Urethritis, Trichomonal
 ;;^UTILITY(U,$J,358.3,3486,2)
 ;;=^266955
 ;;^UTILITY(U,$J,358.3,3487,0)
 ;;=597.80^^33^279^55
 ;;^UTILITY(U,$J,358.3,3487,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3487,1,4,0)
 ;;=4^597.80
 ;;^UTILITY(U,$J,358.3,3487,1,5,0)
 ;;=5^Urethritis, NOS
 ;;^UTILITY(U,$J,358.3,3487,2)
 ;;=Urethritis, NOS^124214
 ;;^UTILITY(U,$J,358.3,3488,0)
 ;;=788.41^^33^279^57
 ;;^UTILITY(U,$J,358.3,3488,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3488,1,4,0)
 ;;=4^788.41
 ;;^UTILITY(U,$J,358.3,3488,1,5,0)
 ;;=5^Urinary Frequency
 ;;^UTILITY(U,$J,358.3,3488,2)
 ;;=^124396
 ;;^UTILITY(U,$J,358.3,3489,0)
 ;;=788.31^^33^279^60
 ;;^UTILITY(U,$J,358.3,3489,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3489,1,4,0)
 ;;=4^788.31
 ;;^UTILITY(U,$J,358.3,3489,1,5,0)
 ;;=5^Urinary Incontinence, Urge
 ;;^UTILITY(U,$J,358.3,3489,2)
 ;;=^260046
 ;;^UTILITY(U,$J,358.3,3490,0)
 ;;=788.20^^33^279^61
 ;;^UTILITY(U,$J,358.3,3490,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3490,1,4,0)
 ;;=4^788.20
 ;;^UTILITY(U,$J,358.3,3490,1,5,0)
 ;;=5^Urinary Retention
 ;;^UTILITY(U,$J,358.3,3490,2)
 ;;=^295812
 ;;^UTILITY(U,$J,358.3,3491,0)
 ;;=112.2^^33^279^63
 ;;^UTILITY(U,$J,358.3,3491,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3491,1,4,0)
 ;;=4^112.2
 ;;^UTILITY(U,$J,358.3,3491,1,5,0)
 ;;=5^Urogenital Candidiasis
 ;;^UTILITY(U,$J,358.3,3491,2)
 ;;=^266866
 ;;^UTILITY(U,$J,358.3,3492,0)
 ;;=600.01^^33^279^5
 ;;^UTILITY(U,$J,358.3,3492,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3492,1,4,0)
 ;;=4^600.01
 ;;^UTILITY(U,$J,358.3,3492,1,5,0)
 ;;=5^BPH with Obstruction
 ;;^UTILITY(U,$J,358.3,3492,2)
 ;;=^329933
 ;;^UTILITY(U,$J,358.3,3493,0)
 ;;=600.10^^33^279^38
 ;;^UTILITY(U,$J,358.3,3493,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3493,1,4,0)
 ;;=4^600.10
 ;;^UTILITY(U,$J,358.3,3493,1,5,0)
 ;;=5^Nod Prostate W/O UR Obst
 ;;^UTILITY(U,$J,358.3,3493,2)
 ;;=^329934
 ;;^UTILITY(U,$J,358.3,3494,0)
 ;;=585.9^^33^279^8
 ;;^UTILITY(U,$J,358.3,3494,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3494,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,3494,1,5,0)
 ;;=5^Chronic Renal Failure
 ;;^UTILITY(U,$J,358.3,3494,2)
 ;;=^332812
